Bausch Health Cos Receivables 2010-2024 | BHC

Bausch Health Cos receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company
Bausch Health Cos Annual Receivables
(Millions of US $)
2023 $1,998
2022 $1,790
2021 $1,775
2020 $1,577
2019 $1,839
2018 $1,865
2017 $2,130
2016 $2,517
2015 $2,687
2014 $2,076
2013 $1,676
2012 $914
2011 $569
2010 $283
2009 $112
Bausch Health Cos Quarterly Receivables
(Millions of US $)
2024-09-30 $2,094
2024-06-30 $2,102
2024-03-31 $2,048
2023-12-31 $1,998
2023-09-30 $1,948
2023-06-30 $1,743
2023-03-31 $1,688
2022-12-31 $1,790
2022-09-30 $1,739
2022-06-30 $1,645
2022-03-31 $1,566
2021-12-31 $1,775
2021-09-30 $1,730
2021-06-30 $1,609
2021-03-31 $1,499
2020-12-31 $1,577
2020-09-30 $1,733
2020-06-30 $1,369
2020-03-31 $1,712
2019-12-31 $1,839
2019-09-30 $1,747
2019-06-30 $1,829
2019-03-31 $1,786
2018-12-31 $1,865
2018-09-30 $2,041
2018-06-30 $1,973
2018-03-31 $1,940
2017-12-31 $2,130
2017-09-30 $2,229
2017-06-30 $2,096
2017-03-31 $2,097
2016-12-31 $2,517
2016-09-30 $2,708
2016-06-30 $2,733
2016-03-31 $2,693
2015-12-31 $2,687
2015-09-30 $2,696
2015-06-30 $2,371
2015-03-31 $2,109
2014-12-31 $2,076
2014-09-30 $1,880
2014-06-30 $1,771
2014-03-31 $1,706
2013-12-31 $1,676
2013-09-30 $1,643
2013-06-30 $1,127
2013-03-31 $1,054
2012-12-31 $914
2012-09-30 $805
2012-06-30 $611
2012-03-31 $614
2011-12-31 $569
2011-09-30 $468
2011-06-30 $435
2011-03-31 $483
2010-12-31 $283
2010-09-30 $291
2010-06-30 $114
2010-03-31 $105
2009-12-31 $112
2009-09-30 $99
2009-06-30 $97
2009-03-31 $83
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.439B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.679B 6.46
Dr Reddy's Laboratories (RDY) India $12.521B 23.96
BridgeBio Pharma (BBIO) United States $4.911B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.335B 14.04
Supernus Pharmaceuticals (SUPN) United States $2.022B 27.53
Taysha Gene Therapies (TSHA) United States $0.334B 54.33
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.104B 0.00
Sol-Gel Technologies (SLGL) Israel $0.015B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00